Clinical Trial Update: Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial evaluated the anti-inflammatory effect of rosiglitazone in lung inflammation using FDG-PET imaging and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Inflammation

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Lung Inflammation | EARLY_Phase 1 | Status: COMPLETED